ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

$2-A-Pack Cigarette Tax A “Significant Deterrent,” NCAB Resolution Says

October 8, 1993

Upton Considers Moving Basic Research Contracts To grants; Staff Changes Possible, Newell Stay

July 22, 1977

NKTR-102 Shows 29 Percent Response in Phase II Study

September 30, 2011

Politicians Applaud CPRIT’s New Direction; UT Gives Waiver To MD Anderson’s DePinho

October 26, 2012

NCAB Supports ACS Effort To Work With Centers

March 1, 1991

NCI CTEP Approved Trials For the Month of July

July 26, 2013